Somatostatin analog withdrawal in patients with acromegaly: an elusive goal?
- PMID: 24736999
- DOI: 10.1007/s12020-014-0262-6
Somatostatin analog withdrawal in patients with acromegaly: an elusive goal?
Comment on
-
Can we predict long-term remission after somatostatin analog withdrawal in patients with acromegaly? Results from a multicenter prospective trial.Endocrine. 2014 Aug;46(3):577-84. doi: 10.1007/s12020-013-0094-9. Epub 2013 Nov 23. Endocrine. 2014. PMID: 24272601
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources